Stocks/AMPH

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

AMPH

↓ PDF (Pro)
Amphastar Pharmaceuticals Inc. Common Stock
HealthcareDrug Manufacturers - Specialty & GenericUnited StatesNASDAQ
$23.33
+2.59%today
MKT CAP
$1.1B
+8.7% · 1Y
Full Financials
Trailing P/E11.8x
Forward P/E6.9x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-4.5%
5y Revenue CAGR+13.0%
5y Earnings CAGR+2.4%
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership29.3%
Institutional Ownership78.1%
Short % of Float18.14%
Days to Cover7.8d
1 Week+6.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
XERS
Xeris Biopharma Holdings Inc. Common Stock
$1.1B6094.717.0----0.00%
ALVO
Alvotech Ordinary Shares
$1.1B4235.119.2----0.00%
EVO
Evotec SE American Depositary Shares
$1.2B5------0.00%
CRON
Cronos Group Inc. Common Share
$990M5------0.00%
COLL
Collegium Pharmaceutical Inc. Common Stock
$1.2B8222.75.6----0.00%
PCRX
Pacira BioSciences Inc. Common Stock
$937M58193.07.0----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total100
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for AMPH.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.